Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00344617
Recruitment Status : Unknown
Verified September 2007 by Singapore National Eye Centre.
Recruitment status was:  Active, not recruiting
First Posted : June 27, 2006
Last Update Posted : September 26, 2007
Information provided by:
Singapore National Eye Centre